
Advanced Drug Delivery Reviews, Год журнала: 2024, Номер unknown, С. 115478 - 115478
Опубликована: Ноя. 1, 2024
Язык: Английский
Advanced Drug Delivery Reviews, Год журнала: 2024, Номер unknown, С. 115478 - 115478
Опубликована: Ноя. 1, 2024
Язык: Английский
AAPS PharmSciTech, Год журнала: 2025, Номер 26(1)
Опубликована: Янв. 8, 2025
Язык: Английский
Процитировано
4Ageing Research Reviews, Год журнала: 2024, Номер 98, С. 102322 - 102322
Опубликована: Май 8, 2024
Язык: Английский
Процитировано
14Pathology - Research and Practice, Год журнала: 2024, Номер 256, С. 155257 - 155257
Опубликована: Март 13, 2024
Язык: Английский
Процитировано
9Drug Delivery and Translational Research, Год журнала: 2025, Номер unknown
Опубликована: Янв. 29, 2025
Язык: Английский
Процитировано
1Drug Discovery Today, Год журнала: 2025, Номер unknown, С. 104330 - 104330
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
1Nano-Micro Letters, Год журнала: 2024, Номер 16(1)
Опубликована: Авг. 13, 2024
Abstract The eye, a complex organ isolated from the systemic circulation, presents significant drug delivery challenges owing to its protective mechanisms, such as blood-retinal barrier and corneal impermeability. Conventional administration methods often fail sustain therapeutic levels may compromise patient safety compliance. Polysaccharide-based microneedles (PSMNs) have emerged transformative solution for ophthalmic delivery. However, comprehensive review of PSMNs in ophthalmology has not been published date. In this review, we critically examine synergy between polysaccharide chemistry microneedle technology enhancing ocular We provide thorough analysis PSMNs, summarizing design principles, fabrication processes, addressed during fabrication, including improving comfort also describe recent advances performance various both research clinical scenarios. Finally, current regulatory frameworks market barriers that are relevant commercial advancement final perspective on area.
Язык: Английский
Процитировано
8Drug Discovery Today, Год журнала: 2024, Номер 29(7), С. 104030 - 104030
Опубликована: Май 17, 2024
Язык: Английский
Процитировано
7International Journal of Pharmaceutics, Год журнала: 2024, Номер 661, С. 124400 - 124400
Опубликована: Июнь 29, 2024
Язык: Английский
Процитировано
6Small Science, Год журнала: 2024, Номер unknown
Опубликована: Июль 21, 2024
Microneedles (MNs) have emerged as a promising transdermal antimicrobial delivery system, providing precise and localized drug while complemented with noninvasiveness patient compliance. Currently, the topical application of antimicrobials restricts drugs to critical areas wound bed, largely due barriers posed by necrotic tissue, scab formation, bacterial biofilms, which severely diminish bioavailability therapeutics. MNs enabled efficient targeted overcome many chronic challenges. Over past decade, significant progress has been made develop unique properties tailored for vaccines, anticancer, antimicrobials. As ongoing research continues refine MN design, material properties, formulations, potential revolutionizing efficacy, experience, therapeutic outcomes remains at forefront scientific research. In this review, insights are provided into latest progress, current developments, diverse applications delivery. Herein, translational is highlighted perspective on challenges associated clinical translation provided. Furthermore, review aids in identifying gaps empowering contributing future implementation cutting‐edge systems effectively tackle resistance.
Язык: Английский
Процитировано
6Drug Delivery and Translational Research, Год журнала: 2024, Номер unknown
Опубликована: Апрель 15, 2024
Язык: Английский
Процитировано
4